Oral dosage form safeguarded against abuse containing (1R, 2R)-3-(3-dimethylamino-1-ethyl-2-meth yl-propyl)-phenol

Details for Australian Patent Application No. 2005259478 (hide)

Owner Gruenenthal GmbH

Inventors Arkenau-Maric, Elisabeth; Bartholomaus, Johannes; Kugelmann, Heinrich

Agent Collison & Co

Pub. Number AU-B-2005259478

PCT Pub. Number WO2006/002886

Priority 10 2004 032 103.5 01.07.04 DE; 10/890,707 14.07.04 US

Filing date 29 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 15 July 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/002886 Priority application(s): WO2006/002886

22 March 2007 Change of Name(s) of Applicant(s), Section 104

  Grunenthal GmbH The name of the applicant has been changed to Gruenenthal GmbH

10 April 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to include co-inventor Arkenau-Maric, Elisabeth 2006

15 July 2010 Application Accepted

  Published as AU-B-2005259478

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259481-Improved adjuvant therapy of G250-expressing tumors

2005259476-Oral dosage form safeguarded against abuse